Mattei, P L <br/><br/>
Cutaneous effects of BRAF inhibitor therapy: a case series.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Feb 2013 
 - 530-537 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mds292  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Squamous Cell--chemically induced<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Indoles--adverse effects<br/>Keratoacanthoma--chemically induced<br/>Keratosis, Actinic--chemically induced<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Oximes--adverse effects<br/>Photosensitivity Disorders--chemically induced<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Pyridones--adverse effects<br/>Pyrimidinones--adverse effects<br/>Retrospective Studies<br/>Skin Diseases--chemically induced<br/>Sulfonamides--adverse effects<br/>Vemurafenib<br/>Warts--chemically induced